|
IARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.891600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.127840E-01 |
| Normal-vs-Stage2 |
5.403000E-01 |
| Normal-vs-Stage3 |
2.594400E-01 |
| Normal-vs-Stage4 |
7.201800E-02 |
| Stage1-vs-Stage2 |
7.868000E-01 |
| Stage1-vs-Stage3 |
3.290300E-02 |
| Stage1-vs-Stage4 |
2.583600E-02 |
| Stage2-vs-Stage3 |
2.055200E-01 |
| Stage2-vs-Stage4 |
4.476000E-02 |
| Stage3-vs-Stage4 |
5.544000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.383800E-01 |
| Normal-vs-AfricanAmerican |
3.816800E-01 |
| Normal-vs-Asian |
7.797200E-01 |
| Caucasian-vs-AfricanAmerican |
6.144000E-01 |
| Caucasian-vs-Asian |
8.424600E-01 |
| AfricanAmerican-vs-Asian |
9.543200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.448400E-02 |
| Normal-vs-Female |
4.956200E-02 |
| Male-vs-Female |
2.756700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.943600E-01 |
| Normal-vs-Extreme_Weight |
1.053960E-02 |
| Normal-vs-Obese |
9.734200E-01 |
| Normal-vs-Extreme_Obese |
9.490400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.186400E-02 |
| Normal_Weight-vs-Obese |
9.752200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.449000E-01 |
| Extreme_Weight-vs-Obese |
7.891900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.335800E-01 |
| Obese-vs-Extreme_Obese |
9.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.654200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.345600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.489400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.447400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.729800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.102500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.768400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.333800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.858800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.593200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.072400E-02 |
| Normal-VS-Type2 PRCC |
2.509000E-01 |
| Normal-VS-KIRP CIMP |
6.520400E-02 |
| Normal-VS-Unclassified PRCC |
8.066800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.269610E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.398200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.243600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.388600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.738800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.034000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.163400E-01 |
| Normal-vs-N1 |
4.291800E-02 |
| Normal-vs-N2 |
1.050620E-01 |
| N0-vs-N1 |
7.137700E-03 |
| N0-vs-N2 |
2.897700E-02 |
| N1-vs-N2 |
4.725000E-01 |
|
|
